Solid phase synthesis of Smac/DIABLO-derived peptides using a 'Safety-Catch' resin Identification of potent XIAP BIR3 antagonists

Mohamed A Elsawy, Lorraine Martin, Irina G Tikhonova, Brian Walker

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The N-terminal sequence of the Smac/DIABLO protein is known to be involved in binding to the BIR3 domain of the anti-apoptotic proteins IAPs, antagonizing their action. Short peptides and peptide mimetics based on the first 4-residues of Smac/DIABLO have been demonstrated to re-sensitize resistant cancer cells, over-expressing IAPs, to apoptosis. Based on the well-defined structural basis for this interaction, a small focused library of C-terminal capped Smac/DIABLO-derived peptides was designed in silico using docking to the XIAP BIR3 domain. The top-ranked computational hits were conveniently synthesized employing Solid Phase Synthesis (SPS) on an alkane sulfonamide 'Safety-Catch' resin. This novel approach afforded the rapid synthesis of the target peptide library with high flexibility for the introduction of various C-terminal amide-capping groups. The library members were obtained in high yield (>65%) and purity (>85%), upon nucleophilic release from the activated resin by treatment with various amine nucleophiles. In vitro caspase-9 activity reconstitution assays of the peptides in the presence of the recombinant BIR3-domain of human XIAP (500nM) revealed N-methylalanyl-tertiarybutylglycinyl-4-(R)-phenoxyprolyl-N-biphenylmethyl carboxamide (11a) to be the most potent XIAP BIR3 antagonist of the series synthesized inducing 93% recovery of caspase-9 activity, when used at 1µM concentration. Compound (11a) also demonstrated moderate cytotoxicity against the breast cancer cell lines MDA-MB-231 and MCF-7, compared to the Smac/DIABLO-derived wild-type peptide sequences that were totally inactive in the same cell lines.
Original languageEnglish
Pages (from-to)5004-5011
JournalBioorganic & Medicinal Chemistry
Volume21
Issue number17
Early online date02 Jul 2013
DOIs
Publication statusPublished - Sep 2013

Bibliographical note

Copyright © 2013 Elsevier Ltd. All rights reserved.

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry
  • Biochemistry

Fingerprint Dive into the research topics of 'Solid phase synthesis of Smac/DIABLO-derived peptides using a 'Safety-Catch' resin Identification of potent XIAP BIR3 antagonists'. Together they form a unique fingerprint.

Cite this